The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis

Journal of Research in Medical Sciences

Volumn 18, Issue 3, 2013, Pages 193-197

  Ashtari, Fereshteh ^a   Ajalli, Masoomeh ^a   Shaygannejad, Vahid ^a   Akbari, Mojtaba ^a   Hovsepian, Silva ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depressive symptom; Fatigue; Multiple sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CORRELATION ANALYSIS; CROSS?SECTIONAL STUDY; DEPRESSION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; PREVALENCE; RADIOIMMUNOASSAY;

EID: 84875164871     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fontoura P, Steinman L, Miller A. Emerging therapeutic targets in multiple sclerosis. Curr Opin Neurol 2006;19:260-6.
2. Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007;68:522-31.
3. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599-612.
4. Hanwell HE, Banwell B. Assessment of evidence for a protective role of Vitamin D in multiple sclerosis. Biochim Biophys Acta 2011;1812:202-12.
5. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009;132:1146-60.
6. Correale J, Ysrraelit MC, Gaitan MI. Vitamin D-mediated immune regulation in multiple sclerosis. J Neurol Sci 2011;311:23-31.
7. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of Vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008;14:1220-4.
8. Haussleiter IS, Brune M, Juckel G. Psychopathology in multiple sclerosis: Diagnosis, prevalence and treatment. Ther Adv Neurol Disord 2009;2:13-29.
9. Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: A review of recent developments. Curr Opin Psychiatry 2007;20:278-85.
10. Kale N, Agaoglu J, Tanik O. Neuropsychiatric manifestations in multiple sclerosis: Correlation of fatigue and depression with disease progression. Neurol Res 2010;32:221-3.
11. Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: A rapid and systematic review. Health Technol Assess 2000;4:1-61.
12. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: A population-based perspective. Neurology 2003;61:1524-7.
13. Knippenberg S, Bol Y, Damoiseaux J, Hupperts R, Smolders J. Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue. Acta Neurol Scand 2011;124:171-5.
14. Stewart R, Hirani V. Relationship between Vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 2010;72:608-12.
15. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080-6S.
16. Bertone-Johnson ER. Vitamin D and the occurrence of depression: Causal association or circumstantial evidence? Nutr Rev 2009;67:481-92.
17. Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, et al. Vitamin D deficiency may play a role in depression. Med Hypotheses 2007;69:1316-9.
18. Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011;17:1022-7.
19. Shaygannejad V, Golabchi K, Haghighi S, Dehghan H, Moshayedi A. A Comparative Study of 25 (OH) Vitamin D Serum Levels in Patients with Multiple Sclerosis and Control Group in Isfahan, Iran. Int J Prev Med 2010;1:195-201.
20. Kilsdonk ID, Barkhof F, Wattjes MP. 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: Impact of 3-Tesla magnetic resonance imaging. Ann Neurol 2011;70:182-3.
21. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of Vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011;29:149-55.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
23. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997;35:785-91.
24. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
25. Holick MF. Vitamine D deficiency. N Engl J Med 2007;357:266-81.
26. Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Vitamin D levels in Hispanics with multiple sclerosis. J Neurol. 2012; 259(12):2565-70.
27. Simon KC, Munger KL, Ascherio A. Vitamin D and multiple sclerosis: Epidemiology, immunology and genetics. Curr Opin Neurol 2012;25:246-51.
28. Disanto G, Morahan JM, Ramagopalan SV. Multiple Sclerosis: Risk Factors and Their Interactions. CNS Neurol Disord Drug Targets 2012;11:545-55.
29. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009;34:S265-77.
30. Ashkanian M, Tehrani E, Videbech P. The effect of Vitamin D on neuropsychiatric conditions. Ugeskr Laeger 2010;172:1296-300.
31. Nimitphong H, Holick MF. Vitamin D, neurocognitive functioning and immunocompetence. Curr Opin Clin Nutr Metab Care 2011;14:7-14.
32. Dorr J, Ohlraun S, Skarabis H, Paul F. Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): Study protocol for a randomized controlled trial. Trials. 2012; Feb 8; 13:15.
33. Yadav V, Shinto L, Bourdette D. Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immnol 2010;6:381-95.
34. th ed. Baltimore, MD: Lippincott Williams and Wilkins; 2006. p. 376-95.
35. Murphy PK, Wagner CL. Vitamin D and mood disorders among women: An integrative review. J Midwifery Womens Health 2008;53:440-6.
36. Crawford PW. Assessment of Depression in Multiple Sclerosis Validity of Including Somatic Items on the Beck Depression Inventory-II. Int J MS Care 2009;11:167-73.
37. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci 2009;1173:384-90.
38. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: Mechanisms, evaluation, and treatment. Sleep 2010;33:1061-7.
39. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-7.
40. Janardhan V, Bakshi R. Quality of life in patients with multiplesclerosis: The impact of fatigue and depression. J Neurol Sci 2002;205:51-8.